CONTACT US   |  (864) 397-5101

Loading Events

Event Details

Founder’s Workshop Charleston!

Calling all founders and officers of Emerging Life Sciences companies…

Join SCbio for a Workshop designed to help founders navigate relevant topics including working with big pharma, growing a company, fundraising and pitch deck development, accounting for growth, and regulatory & compliance.

This will be a working lunch.

Agenda:

Welcome – James Chappell, Ph.D., SCbio

Working with Leading Life Sciences Companies in Med Tech & Pharma

  • Patrick Coyle, MBA, Founder & CEO, Novus Proximus
  • Sarah Kleinpeter, Vice President Alzheimer’s Disease, Novo Nordisk

 Growing a company

  • Todd Headley, Chief Executive Officer, MUSC Zucker Institute for Innovation Commercialization (ZI) – moderater
  • Robert Ryan, Ph.D., Chief Executive Officer, Innova Therapeutics, Inc.
  • Patrick Coyle, MBA, Founder & CEO, Novus Proximus
  • Justin Burns, Ph.D., Investment Professional, Morningside

Break and lunch                

Fundraising/Pitch deck

  • Herbert Drayton, Managing Partner, HI Mark Capital
  • Justin Burns, Ph.D., Investment Professional, Morningside
  • Robert Ryan, Ph.D., Chief Executive Officer, Innova Therapeutics, Inc.
  • Juliette Bogus, President, Inspire Agency

Accounting for Growth

  • Cindy Brams, CPA, Shareholder, Elliott Davis
  • Brandon Thomas, CPA, Principal, Elliott Davis
  • Dan Bailey, CPA, Principal, Elliott Davis

(5-minute break)

Regulatory & Compliance

  • Christopher Hanson, Partner, Nelson Mullins Riley & Scarborough

Open to SCbio Members only.

If you’re interesting in learning more about membership opportunities, please email our Investor Relations & Engagement Director, Carla Whitlock.

Tamia Sumpter

Tamia is a driven senior undergraduate Bioengineering student currently enrolled at Clemson University. With a strong foundation in her field, she has honed her skills through hands-on experience in research and development at Eli Lilly & Company. During her time in the ADME department, Tamia contributed significantly by working on siRNAs and their applications in finding In Vitro-In Vivo Correlation (IVIVC). Looking ahead, Tamia has set her sights on a promising career in law. She aspires to specialize in Intellectual Property Law, with a particular focus on serving as in-house counsel for leading medical device or pharmaceutical companies. Her enthusiasm for this role is palpable as she prepares to embark on her legal journey! She is also a proud member of the Omicron Phi chapter of Delta Sigma Theta Sorority, Inc., PEER Mentor for Clemson PEER/WiSE, and currently serves as the President of Clemson Bioengineering Organization (CBO). With her unique blend of scientific knowledge and legal interests, Tamia is poised to make a meaningful impact in the healthcare and life sciences industries.